Ningbo Menovo Pharm Co Ltd Cash Flow Reinvestment Rate
Ningbo Menovo Pharm Co Ltd cash flow reinvestment rate. Ningbo Menovo Pharm Co Ltd (603538) has a Cash Flow Reinvestment Rate of 0.12x as of September 2025, reinvesting CN¥4.60 Million (capex CN¥4.60 Million ) from operating cash flow of CN¥38.86 Million. Explore Ningbo Menovo Pharm Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Ningbo Menovo Pharm Co Ltd (2011–2025)
Cash flow reinvestment rate of Ningbo Menovo Pharm Co Ltd from 2011 to 2025. Historical reinvestment intensity for Ningbo Menovo Pharm Co Ltd across 15 annual periods. Explore capital reinvestment ratio of Ningbo Menovo Pharm Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Ningbo Menovo Pharm Co Ltd Cash Flow Reinvestment Rate by Year (2011–2025)
Ningbo Menovo Pharm Co Ltd cash flow reinvestment rate by year from 2011 to 2025. Year-by-year capital reinvestment analysis for Ningbo Menovo Pharm Co Ltd. For the full cash flow conversion analysis, see 603538 cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.77x | CN¥120.93 Million | CN¥157.56 Million | CN¥112.08 Million | ▼ -70.9% |
| 2024 | 2.63x | CN¥256.85 Million | CN¥97.54 Million | CN¥179.40 Million | ▼ -95.6% |
| 2023 | 59.47x | CN¥543.15 Million | CN¥9.13 Million | CN¥219.54 Million | ▲ +2548.5% |
| 2022 | 2.25x | CN¥621.88 Million | CN¥276.95 Million | CN¥571.62 Million | ▼ -20.1% |
| 2021 | 2.81x | CN¥620.14 Million | CN¥220.63 Million | CN¥529.89 Million | ▲ +43.0% |
| 2020 | 1.97x | CN¥494.71 Million | CN¥251.61 Million | CN¥311.74 Million | ▼ -4.2% |
| 2019 | 2.05x | CN¥368.93 Million | CN¥179.75 Million | CN¥328.07 Million | ▼ -69.7% |
| 2018 | 6.77x | CN¥315.42 Million | CN¥46.60 Million | CN¥299.59 Million | ▲ +33.2% |
| 2017 | 5.08x | CN¥407.33 Million | CN¥80.15 Million | CN¥86.22 Million | ▲ +314.2% |
| 2016 | 1.23x | CN¥143.84 Million | CN¥117.24 Million | CN¥108.84 Million | ▲ +165.9% |
| 2015 | 0.46x | CN¥61.56 Million | CN¥133.42 Million | CN¥61.56 Million | ▼ -24.8% |
| 2014 | 0.61x | CN¥46.14 Million | CN¥75.22 Million | CN¥46.14 Million | ▲ +21.3% |
| 2013 | 0.51x | CN¥75.44 Million | CN¥149.21 Million | CN¥75.44 Million | ▼ -76.4% |
| 2012 | 2.14x | CN¥81.72 Million | CN¥38.11 Million | CN¥81.72 Million | ▲ +63.4% |
| 2011 | 1.31x | CN¥159.71 Million | CN¥121.67 Million | CN¥159.71 Million | — |